BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8471047)

  • 1. Genetic variation of iron-induced uroporphyria in mice.
    Smith AG; Francis JE
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):29-35. PubMed ID: 8471047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice.
    Constantin D; Francis JE; Akhtar RA; Clothier B; Smith AG
    Biochem Pharmacol; 1996 Nov; 52(9):1407-13. PubMed ID: 8937451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.
    Smith AG; Francis JE
    Biochem J; 1987 Aug; 246(1):221-6. PubMed ID: 3675556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uroporphyria produced in mice by iron and 5-aminolevulinic acid.
    Deam S; Elder GH
    Biochem Pharmacol; 1991 Jun; 41(12):2019-22. PubMed ID: 2039550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice.
    Hahn ME; Gasiewicz TA; Linko P; Goldstein JA
    Biochem J; 1988 Aug; 254(1):245-54. PubMed ID: 2845946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid.
    Urquhart AJ; Elder GH; Roberts AG; Lambrecht RW; Sinclair PR; Bement WJ; Gorman N; Sinclair JA
    Biochem J; 1988 Jul; 253(2):357-62. PubMed ID: 3178718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
    Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
    Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Possible relevance to drug-induced uroporphyria.
    De Matteis F; Harvey C; Reed C; Hempenius R
    Biochem J; 1988 Feb; 250(1):161-9. PubMed ID: 3128275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Dalton TP; Sinclair JF; Smith AG; Nebert DW
    Toxicol Appl Pharmacol; 2000 Jan; 162(1):60-7. PubMed ID: 10631128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice.
    Smith AG; Francis JE
    Biochem J; 1983 Sep; 214(3):909-13. PubMed ID: 6626162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice.
    Gorman N; Walton HS; Bement WJ; Honsinger CP; Szakacs JG; Sinclair JF; Sinclair PR
    Biochem Pharmacol; 1999 Jul; 58(2):375-82. PubMed ID: 10423181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron.
    Gorman N; Ross KL; Walton HS; Bement WJ; Szakacs JG; Gerhard GS; Dalton TP; Nebert DW; Eisenstein RS; Sinclair JF; Sinclair PR
    Hepatology; 2002 Apr; 35(4):912-21. PubMed ID: 11915039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
    Nakano K; Ishizuka M; Sakamoto KQ; Fujita S
    Biometals; 2009 Apr; 22(2):345-51. PubMed ID: 18956144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
    Sinclair PR; Gorman N; Dalton T; Walton HS; Bement WJ; Sinclair JF; Smith AG; Nebert DW
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):149-53. PubMed ID: 9461503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uroporphyria in the Cyp1a2-/- mouse.
    Phillips JD; Kushner JP; Bergonia HA; Franklin MR
    Blood Cells Mol Dis; 2011 Dec; 47(4):249-54. PubMed ID: 21880518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against iron-induced uroporphyria in C57BL/10ScSn mice by the peroxisome proliferator nafenopin.
    Smith AG; Francis JE; Walters DG; Lake BG
    Biochem Pharmacol; 1990 Dec; 40(11):2564-8. PubMed ID: 2268375
    [No Abstract]   [Full Text] [Related]  

  • 17. Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations.
    Francis JE; Smith AG
    Biochem Biophys Res Commun; 1987 Jul; 146(1):13-20. PubMed ID: 3606611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inhibition of uroporphyrinogen decarboxylase in PCB-induced porphyria in mice.
    Seki Y; Kawanishi S; Sano S
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):116-25. PubMed ID: 3114913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress.
    Clothier B; Robinson S; Akhtar RA; Francis JE; Peters TJ; Raja K; Smith AG
    Biochem Pharmacol; 2000 Jan; 59(2):115-22. PubMed ID: 10810445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-ahr gene susceptibility Loci for porphyria and liver injury induced by the interaction of 'dioxin' with iron overload in mice.
    Robinson SW; Clothier B; Akhtar RA; Yang AL; Latour I; Van Ijperen C; Festing MF; Smith AG
    Mol Pharmacol; 2002 Mar; 61(3):674-81. PubMed ID: 11854449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.